BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 15378790)

  • 1. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
    Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
    World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
    İlhan Ö; Han Ü; Önal B; Çelık SY
    Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
    Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
    Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
    Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
    Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.
    Silva EM; Begnami MD; Fregnani JH; Pelosof AG; Zitron C; Montagnini AL; Soares FA
    Gastric Cancer; 2008; 11(3):149-59. PubMed ID: 18825309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
    Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
    Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features.
    Wang RQ; Fang DC
    J Clin Pathol; 2003 May; 56(5):378-84. PubMed ID: 12719460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
    Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
    Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucin antigen expression in gastric carcinomas of young and old adults.
    Sakamoto H; Yonezawa S; Utsunomiya T; Tanaka S; Kim YS; Sato E
    Hum Pathol; 1997 Sep; 28(9):1056-65. PubMed ID: 9308730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S; Sato E
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
    Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
    World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
    Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
    Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of mucin MUC1 and MUC2 in colorectal carcinoma and their clinical significance].
    Huang WB; Shi LH; Zhu XQ; Xu GX; Qi Q
    Ai Zheng; 2002 Nov; 21(11):1231-4. PubMed ID: 12526222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
    Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
    Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF; Xiao H; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.